Two drugs to be studied in North America and Europe in volunteers at high risk for disease Copenhagen, Denmark (July 15, 2014) —Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs—an active immunotherapy and an oral medication—can prevent or […]
CONTINUE READING7/15/14 A Phoenix-area research group (Banner Alzheimer’s Institute and its research partners) will team with Swiss pharmaceutical company Novartis to test two experimental drugs that aim to fend off Alzheimer’s disease in older adults who are at high risk but have not yet shown memory or thinking problems. Click here to read the full article.
CONTINUE READINGDr. Carol Barnes has been recognized by the American Psychological Association as a 2014 Distinguished Scientific Contribution award recipient. The award recognizes senior scientists for distinguished theoretical or empirical contributions to basic research in psychology. Dr. Barnes will be presented the award at the APA convention to be held August 7-10 in Washington, D.C. http://uaatwork.arizona.edu/lqp/carol-barnes-recognized-american-psychological-association-major-scientific-contributions?utm_source=lqp&utm_medium=email&utm_campaign=weekly_lqp%3E
CONTINUE READINGTgen’s MindCrowd, an online cognitive study, is hoping a million people worldwide will spend 10 minutes taking their online test. With the knowledge they glean from the results, they plan to better understand age’s effect on memory and use that information to help prevent diseases like Alzheimer’s. Click here to read the full article.
CONTINUE READINGDr. Eric Reiman and Dr. Adam Fleisher of Banner Alzheimer’s Institute speak with CBS Sunday Morning about their research work and the hope that one family in Colombia is giving to Alzheimer’s patients all over the world. Click here to view the original article
CONTINUE READING9/18/13 PHOENIX - In collaboration with the National Institutes of Health (NIH), Banner Alzheimer’s Institute (BAI) announces a major prevention trial to evaluate a treatment in cognitively healthy older adults at the highest known genetic risk for developing Alzheimer’s disease at older ages. An NIH grant, expected to total $33.2 million, will support this research. Read the […]
CONTINUE READING9/18/13 PHOENIX - Recognizing the need to accelerate research to prevent Alzheimer’s disease and engage consumers, Banner Alzheimer’s Institute (BAI) announced a major multi-corporation partnership today. The Global CEO Initiative on Alzheimer’s disease (CEOi) and many of its member companies including: Bank of America, GE Healthcare, Janssen Research and Development, LLC., and Merck will partner together […]
CONTINUE READING1/24/2013 SAN DIEGO – The American Academy of Neurology and the American Brain Foundation are awarding the 2013 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases to William J. Jagust, MD, with the University of California, Berkeley, Michael W. Weiner, MD, with the San Francisco VA Medical Center in San Francisco and Eric […]
CONTINUE READING2/4/2013 State-of-the-art center to foster the continuation of pioneering imaging research PHOENIX, Ariz. (Feb. 5, 2013) – The opening of a $16.3 million state-of-the-art Imaging Center further cements the internationally-recognized work occurring at Banner Alzheimer’s Institute (BAI) and advances statewide collaboration in Alzheimer’s disease and other neuroscientific, cardiology and oncology research. Read the press release […]
CONTINUE READING